3rd Annual Cedars-Sinai Gastrointestinal Tumor Conference: Advances in Immunotherapy for Gastrointestinal Cancers

CME

Advertisement

The third annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in immunotherapy for gastrointestinal cancers. A stellar faculty will discuss developments in precision medicine and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and stomach/esophagus. Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for immunotherapy in neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities and the results of combining radiation and immunotherapy.

4 AMA PRA Category 1 Credits™

Venue: Cedars-Sinai Medical Center, Harvey Morse Conference Center

Date

September 12, 2020

Location

Los Angeles, California 90048, United States

Email

cme@cshs.org

Website

cedars.cloud-cme.com/default.aspx?P=5& EID=9021/

Advertisement